OncoSec Medical Inc. , a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will present at four events in June. The company’s agenda includes a number of high-profile scientific and investment conferences, coming on the heels of their presentation of new clinical data at the 2014 ASCO Annual Meeting.
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1kH0uGc
via IFTTT
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1kH0uGc
via IFTTT
No comments:
Post a Comment